当前位置:
X-MOL 学术
›
Am. J. Ophthalmol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Using Real-World Data to Assess the Association of Retinal Detachment with Topical Pilocarpine Use.
American Journal of Ophthalmology ( IF 4.1 ) Pub Date : 2024-11-05 , DOI: 10.1016/j.ajo.2024.10.035 Abdelrahman M Elhusseiny,Muhammad Z Chauhan,Sayena Jabbehdari,Nayef Alshammari,Sarah Jong,Paul H Phillips,Ahmed B Sallam
American Journal of Ophthalmology ( IF 4.1 ) Pub Date : 2024-11-05 , DOI: 10.1016/j.ajo.2024.10.035 Abdelrahman M Elhusseiny,Muhammad Z Chauhan,Sayena Jabbehdari,Nayef Alshammari,Sarah Jong,Paul H Phillips,Ahmed B Sallam
PURPOSE
To examine the association between topical pilocarpine and the risk of new-onset rhegmatogenous retinal detachment (RRD).
DESIGN
Retrospective clinical cohort study.
METHODS
We used an aggregated electronic health records research network, TriNetX, to examine the risk of RRD (ICD-10: H33.0x) following the initiation of pilocarpine. The primary study group included adult patients over 40 years who received topical pilocarpine (1.25% or any dose with the exclusion of other indications) for the first time. Our control group consisted of patients with presbyopia who were started on artificial tears and had no history of topical pilocarpine use during the study period. We matched both cohorts using propensity score matching (PSM) based on demographics, systemic comorbidities, and known risk factors for RRD.
RESULTS
After matching, the three-month risk of RRD was significantly higher in the pilocarpine group (0.53%) compared to the control (0.25%) (RR: 2.18, 95% CI: 1.07-4.45, p=0.03). The 6-month risk of RRD remained elevated at 0.60% in the study group versus 0.31% in the control group (RR: 1.93, 95% CI: 1.01-3.67, p=0.04). At one year, the risk increased to 0.78% in the pilocarpine group and 0.33% in the control group (RR: 2.33, 95% CI: 1.28-4.27, p=0.005). A Cox proportional hazards model indicated that pilocarpine use was associated with a 3.14-fold increased risk of RRD (95% CI: 1.66-5.93, p<0.001) compared to controls, after adjusting for demographics and comorbidities. Additional risk factors for RRD included male sex (aHR: 2.36, p=0.001), myopia (aHR: 2.36, p=0.001), vitreous degeneration (aHR: 2.22, p=0.020), lattice degeneration (aHR: 3.71, p=0.010), and pseudophakia (aHR: 3.48, p<0.001).
CONCLUSIONS
Our study quantified the increased risk of RRD associated with topical pilocarpine use.
中文翻译:
使用真实世界数据评估视网膜脱离与局部毛果芸香碱使用的关系。
目的 检查局部毛果芸香碱与新发孔源性视网膜脱离 (RRD) 风险之间的关联。设计 回顾性临床队列研究。方法 我们使用聚合的电子健康记录研究网络 TriNetX 来检查毛果芸香碱开始后 RRD (ICD-10: H33.0x) 的风险。主要研究组包括 40 岁以上首次接受局部毛果芸香碱 (1.25% 或排除其他适应症的任何剂量) 的成年患者。我们的对照组由老花眼患者组成,他们从人工泪液开始,在研究期间没有局部毛果芸香碱使用史。我们使用基于人口统计学、全身性合并症和已知 RRD 危险因素的倾向评分匹配 (PSM) 对两个队列进行匹配。结果 匹配后,毛果芸香碱组 (0.53%) 的 3 个月 RRD 风险显著高于对照组 (0.25%) (RR: 2.18,95% CI: 1.07-4.45,p=0.03)。研究组 RRD 的 6 个月风险仍然升高至 0.60%,而对照组为 0.31% (RR: 1.93,95% CI: 1.01-3.67,p = 0.04)。一年时,毛果芸香碱组的风险增加到 0.78%,对照组增加到 0.33% (RR: 2.33,95% CI: 1.28-4.27,p=0.005)。Cox 比例风险模型表明,在调整人口统计学和合并症后,与对照组相比,毛果芸香碱的使用与 RRD 风险增加 3.14 倍相关 (95% CI: 1.66-5.93,p<0.001)。RRD 的其他危险因素包括男性 (aHR: 2.36, p=0.001)、近视 (aHR: 2.36, p=0.001)、玻璃体变性 (aHR: 2.22, p=0.020)、晶格变性 (aHR: 3.71, p=0.010) 和假晶状体 (aHR: 3.48, p<0.001)。 结论 我们的研究量化了与局部毛果芸香碱使用相关的 RRD 风险增加。
更新日期:2024-11-05
中文翻译:
使用真实世界数据评估视网膜脱离与局部毛果芸香碱使用的关系。
目的 检查局部毛果芸香碱与新发孔源性视网膜脱离 (RRD) 风险之间的关联。设计 回顾性临床队列研究。方法 我们使用聚合的电子健康记录研究网络 TriNetX 来检查毛果芸香碱开始后 RRD (ICD-10: H33.0x) 的风险。主要研究组包括 40 岁以上首次接受局部毛果芸香碱 (1.25% 或排除其他适应症的任何剂量) 的成年患者。我们的对照组由老花眼患者组成,他们从人工泪液开始,在研究期间没有局部毛果芸香碱使用史。我们使用基于人口统计学、全身性合并症和已知 RRD 危险因素的倾向评分匹配 (PSM) 对两个队列进行匹配。结果 匹配后,毛果芸香碱组 (0.53%) 的 3 个月 RRD 风险显著高于对照组 (0.25%) (RR: 2.18,95% CI: 1.07-4.45,p=0.03)。研究组 RRD 的 6 个月风险仍然升高至 0.60%,而对照组为 0.31% (RR: 1.93,95% CI: 1.01-3.67,p = 0.04)。一年时,毛果芸香碱组的风险增加到 0.78%,对照组增加到 0.33% (RR: 2.33,95% CI: 1.28-4.27,p=0.005)。Cox 比例风险模型表明,在调整人口统计学和合并症后,与对照组相比,毛果芸香碱的使用与 RRD 风险增加 3.14 倍相关 (95% CI: 1.66-5.93,p<0.001)。RRD 的其他危险因素包括男性 (aHR: 2.36, p=0.001)、近视 (aHR: 2.36, p=0.001)、玻璃体变性 (aHR: 2.22, p=0.020)、晶格变性 (aHR: 3.71, p=0.010) 和假晶状体 (aHR: 3.48, p<0.001)。 结论 我们的研究量化了与局部毛果芸香碱使用相关的 RRD 风险增加。